Lifecore Biomedical, Inc. Common Stock (LFCR) is a publicly traded Healthcare sector company. As of May 21, 2026, LFCR trades at $4.57 with a market cap of $164.29M and a P/E ratio of -3.53. LFCR moved +4.34% today. Year to date, LFCR is -41.41%; over the trailing twelve months it is -31.07%. Its 52-week range spans $3.63 to $8.98. Analyst consensus is strong buy with an average price target of $6.67. Rallies surfaces LFCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Lifecore Biomedical, Inc. Common Stock (LFCR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LFCR moved +4.34% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $4.57 |
| Market Cap | $164.29M |
| P/E Ratio | -3.53 |
| EPS | $-1.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.98 |
| 52-Week Low | $3.63 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $128.87M |
| Net Income | $-38.72M |
| Gross Margin | 31.27% |
4 analysts cover LFCR: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.67.